Angiotensin-(1-7) Activates POMC Neurons in the Arcuate Nucleus of the Hypothalamus Through a<i>M as</i>Receptor-Mediated Mechanism

Angiotensin-(1-7) is a protective hormone of the renin-angiotensin system that is well recognized to lower blood pressure and improve metabolic function in animal models of cardiovascular-related diseases; however, the precise mechanisms involved remain incompletely understood. Recent data from our laboratory suggests that the blood pressure lowering effects of angiotensin-(1-7) could occur through a central mechanism of action by inhibiting sympathetic activity to cardiovascular end organs. We have shown that angiotensin-(1-7) mas receptors highly colocalize to proopiomelanocortin (POMC) neurons in the arcuate nucleus of the hypothalamus (ARC), making these neurons a potential target for angiotensin-(1-7) cardiometabolic actions. In this study, we hypothesized that angiotensin-(1-7) activates POMC neurons in the ARC in a ma s receptor-dependent manner. To test this, we used male and female POMC-GFP mice to selectively target POMC neurons in the ARC. We assessed action potential firing of ARC POMC neurons following bath application of 100 nM angiotensin-(1-7) using cell attached patch clamp electrophysiology (n=7-10 cells per group). Angiotensin-(1-7) increased action potential firing of POMC neurons from baseline with no difference in angiotensin-(1-7) responsiveness between sexes (174±26% change in males vs. 133±12% change in females; one-sample t-test p=0.028 males vs. p=0.024 females; unpaired t-test p=0.127). To assess whether this increase in action potential firing occurred through a mas receptor mediated mechanism, we pretreated ARC slices with the selective mas receptor antagonist A779 (1 uM) for at least 30 minutes. Pretreatment with A779 prevented the increase in action potential firing following 100nM angiotensin-(1-7) bath application (106±13% change in males vs. 99±9% change in females; one-sample t-test p=0.549 males vs. p=0.884 females; unpaired t-test p=0.534). We also explored the neurotransmitter identity of ARC POMC neurons that express mas receptor using RNAscope in situ hybridization. We found that nearly 75% of POMC neurons in the ARC co-express mas receptor and mRNA for the vesicular GABA transporter (Vgat). Based on these data, we propose that angiotensin-(1-7) activates GABAergic subpopulations of POMC neurons in the ARC through a mas receptor-mediated mechanism, which may lead to a downstream inhibition of cardiovascular sympathetic activity. Additional studies are ongoing to further test this mechanism of action as well as to examine the impact of angiotensin-(1-7) on activity of ARC POMC neurons in the context of diet-induced obesity. Overall, these data provide new insight into central circuits engaged by angiotensin-(1-7). Funding: NIH F31 HL170693, NIH R01 HL156986 This abstract was presented at the American Physiology Summit 2025 and is only available in HTML format. There is no downloadable file or PDF version. The Physiology editorial board was not involved in the peer review process.

Authors

Institutions

Publication Details

Journal
Physiology
Published
2025-05-01
DOI
https://doi.org/10.1152/physiol.2025.40.s1.0255
Primary Topic
Apelin-related biomedical research
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Angiotensin-(1-7) Activates POMC Neurons in the Arcuate Nucleus of the Hypothalamus Through aM asReceptor-Mediated Mechanism

Amy Christine Arnold, Sarah S. Bingaman, Victoria Vernail, Yuval Silberman
Physiology
Apelin-related biomedical research
article

Angiotensin-(1-7) Activates POMC Neurons in the Arcuate Nucleus of the Hypothalamus Through aM asReceptor-Mediated Mechanism

Amy Christine Arnold, Sarah S. Bingaman, Victoria Vernail, Yuval Silberman
article en

Abstract

Angiotensin-(1-7) is a protective hormone of the renin-angiotensin system that is well recognized to lower blood pressure and improve metabolic function in animal models of cardiovascular-related diseases; however, the precise mechanisms involved remain incompletely understood. Recent data from our laboratory suggests that the blood pressure lowering effects of angiotensin-(1-7) could occur through a central mechanism of action by inhibiting sympathetic activity to cardiovascular end organs. We have shown that angiotensin-(1-7) mas receptors highly colocalize to proopiomelanocortin (POMC) neurons in the arcuate nucleus of the hypothalamus (ARC), making these neurons a potential target for angiotensin-(1-7) cardiometabolic actions. In this study, we hypothesized that angiotensin-(1-7) activates POMC neurons in the ARC in a ma s receptor-dependent manner. To test this, we used male and female POMC-GFP mice to selectively target POMC neurons in the ARC. We assessed action potential firing of ARC POMC neurons following bath application of 100 nM angiotensin-(1-7) using cell attached patch clamp electrophysiology (n=7-10 cells per group). Angiotensin-(1-7) increased action potential firing of POMC neurons from baseline with no difference in angiotensin-(1-7) responsiveness between sexes (174±26% change in males vs. 133±12% change in females; one-sample t-test p=0.028 males vs. p=0.024 females; unpaired t-test p=0.127). To assess whether this increase in action potential firing occurred through a mas receptor mediated mechanism, we pretreated ARC slices with the selective mas receptor antagonist A779 (1 uM) for at least 30 minutes. Pretreatment with A779 prevented the increase in action potential firing following 100nM angiotensin-(1-7) bath application (106±13% change in males vs. 99±9% change in females; one-sample t-test p=0.549 males vs. p=0.884 females; unpaired t-test p=0.534). We also explored the neurotransmitter identity of ARC POMC neurons that express mas receptor using RNAscope in situ hybridization. We found that nearly 75% of POMC neurons in the ARC co-express mas receptor and mRNA for the vesicular GABA transporter (Vgat). Based on these data, we propose that angiotensin-(1-7) activates GABAergic subpopulations of POMC neurons in the ARC through a mas receptor-mediated mechanism, which may lead to a downstream inhibition of cardiovascular sympathetic activity. Additional studies are ongoing to further test this mechanism of action as well as to examine the impact of angiotensin-(1-7) on activity of ARC POMC neurons in the context of diet-induced obesity. Overall, these data provide new insight into central circuits engaged by angiotensin-(1-7). Funding: NIH F31 HL170693, NIH R01 HL156986 This abstract was presented at the American Physiology Summit 2025 and is only available in HTML format. There is no downloadable file or PDF version. The Physiology editorial board was not involved in the peer review process.

PhysiologyVol. 40(S1)
Pennsylvania State University (US), Penn State Milton S. Hershey Medical Center (US)
Openalex Percentile: Top 83%
Apelin-related biomedical research
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.